10 Aug 2022 Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic Member news
08 Aug 2022 Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING® Member news
01 Aug 2022 Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial Member news
26 Jul 2022 Precirix and Eckert & Ziegler sign agreement on priority supply of the therapeutic radioisotope Actinium-225 Member news
19 Jul 2022 Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study and reports disease-modifying profile for Short Term DSR Member news
13 Jul 2022 Agomab raises additional $40.5 million through Series B extension bringing total amount to $114 million Member news
05 Jul 2022 ANeuroTech receives positive feedback from the FDA for its pivotal Phase IIIb development programme for ANT-01 as an adjunctive anti-depression drug for Major Depressive Disorder Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
